Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433726
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-13
Brief Title:
A Phase l Study of By101921 an Oral PARP7 Inhibitor in Patients With Advanced Solid Tumors
Sponsor:
Chengdu Baiyu Pharmaceutical Co Ltd
Organization:
Chengdu Baiyu Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-13
First Submit QC Date:
May 27 2024
Study First Post Date:
2024-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-27
Last Update Post Date:
2024-05-30
Last Update Post Date Type:
ACTUAL